• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干眼相关生活质量评分问卷的编制与验证。

Development and validation of the Dry Eye-Related Quality-of-Life Score questionnaire.

机构信息

Department of Ophthalmology, Ehime University School of Medicine, Ehime, Japan.

出版信息

JAMA Ophthalmol. 2013 Oct;131(10):1331-8. doi: 10.1001/jamaophthalmol.2013.4503.

DOI:10.1001/jamaophthalmol.2013.4503
PMID:23949096
Abstract

IMPORTANCE

A validated questionnaire that assesses symptoms and the effect of dry eye disease (DED) on the patient's daily life is needed to evaluate the condition.

OBJECTIVE

To develop and validate the Dry Eye-Related Quality-of-Life Score (DEQS) questionnaire in Japan.

DESIGN, SETTING, AND PARTICIPANTS: Development and evaluation of the DEQS questionnaire were conducted in 4 phases: (1) item generation, (2) pilot study to assess content and face validity, (3) preliminary psychometric validation study to examine factor structure and reduce the number of items, and (4) final psychometric validation with 224 participants (203 with DED and 21 serving as controls). Participants completed the DEQS questionnaire, the Short Form-8, and the National Eye Institute Visual Function Questionnaire-25. To evaluate reproducibility and responsiveness, individuals with DED completed the DEQS questionnaire twice.

MAIN OUTCOMES AND MEASURES

Internal consistency, reproducibility, discriminant validity, concurrent validity, and responsiveness.

RESULTS

Items were generated from a literature review, and 35 items were selected for the draft version. In the pilot study, 11 items were deleted; furthermore, 9 items were deleted based on the results of item analysis and factor analysis in the preliminary validation study. The final 15-item DEQS questionnaire consisted of an Overall Summary scale and 2 multi-item subscales: Impact on Daily Life and Bothersome Ocular Symptoms. The psychometric analysis revealed that the DEQS questionnaire has good internal consistency, test-retest reliability, discriminant validity, and responsiveness to change. The DEQS questionnaire correlated well with the mental component of the Short Form-8 and showed strong correlations with 4 subscales (Ocular Pain, Near Vision, Distance Vision, and Mental Health) of the National Eye Institute Visual Function Questionnaire-25.

CONCLUSIONS AND RELEVANCE

The DEQS questionnaire is valid and reliable for evaluating the multifaceted effect of DED on the patient's daily life, including mental health, and it can be used easily in routine clinical practice.

摘要

重要性

需要一种经过验证的问卷来评估干眼症 (DED) 患者的症状和疾病对日常生活的影响。

目的

在日本开发和验证干眼相关生活质量评分 (DEQS) 问卷。

设计、设置和参与者:DEQS 问卷的开发和评估分为 4 个阶段进行:(1)项目生成,(2)评估内容和表面有效性的试点研究,(3)初步心理测量验证研究,以检查结构和减少项目数量,以及 (4) 对 224 名参与者(203 名患有 DED,21 名作为对照)进行最终心理测量验证。参与者完成了 DEQS 问卷、简短形式-8 和国家眼科研究所视觉功能问卷-25。为了评估可重复性和反应性,患有 DED 的个体两次完成了 DEQS 问卷。

主要结果和措施

内部一致性、可重复性、判别有效性、同时有效性和反应性。

结果

从文献综述中生成项目,并选择了 35 个项目作为草案。在试点研究中,删除了 11 个项目;此外,根据初步验证研究中的项目分析和因素分析结果,删除了 9 个项目。最终的 15 项 DEQS 问卷包括一个总体摘要量表和 2 个多项目子量表:日常生活影响和眼部不适症状。心理测量分析表明,DEQS 问卷具有良好的内部一致性、测试-重测可靠性、判别有效性和对变化的反应性。DEQS 问卷与简短形式-8 的心理成分相关良好,与国家眼科研究所视觉功能问卷-25 的 4 个子量表(眼部疼痛、近视力、远视力和心理健康)呈强相关。

结论和相关性

DEQS 问卷可有效可靠地评估 DED 对患者日常生活的多方面影响,包括心理健康,并且易于在常规临床实践中使用。

相似文献

1
Development and validation of the Dry Eye-Related Quality-of-Life Score questionnaire.干眼相关生活质量评分问卷的编制与验证。
JAMA Ophthalmol. 2013 Oct;131(10):1331-8. doi: 10.1001/jamaophthalmol.2013.4503.
2
Reliability, validity, and responsiveness of the Thai version of the Dry Eye-Related Quality-of-Life Score questionnaire.干眼症相关生活质量评分问卷泰文版的信度、效度和反应度。
PLoS One. 2022 Jul 19;17(7):e0271228. doi: 10.1371/journal.pone.0271228. eCollection 2022.
3
Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version.25项美国国立眼科研究所视觉功能问卷(NEI VFQ - 25)日语版的心理测量学特性。
Health Qual Life Outcomes. 2005 Oct 26;3:65. doi: 10.1186/1477-7525-3-65.
4
Thai version of the dry eye-related quality-of-life score questionnaire: preliminary assessment for psychometric properties.干眼症相关生活质量评分问卷的泰文版本:心理测量特性的初步评估。
BMC Ophthalmol. 2021 Aug 28;21(1):310. doi: 10.1186/s12886-021-02077-0.
5
Development of a social inclusion index to capture subjective and objective life domains (Phase II): psychometric development study.发展一个社会包容指数来捕捉主观和客观的生活领域(第二阶段):心理测量发展研究。
Health Technol Assess. 2012;16(1):iii-vii, ix-xii, -1-241. doi: 10.3310/hta16010.
6
Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients.开发和验证干眼对日常生活的影响(IDEEL)问卷,这是一种患者报告的结局(PRO)测量工具,用于评估干眼对患者的负担。
Health Qual Life Outcomes. 2011 Dec 8;9:111. doi: 10.1186/1477-7525-9-111.
7
The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).眼部过敏患者影响问卷(EAPIQ)的信度、效度及初步反应性
Health Qual Life Outcomes. 2005 Oct 31;3:67. doi: 10.1186/1477-7525-3-67.
8
The Computer-Vision Symptom Scale (CVSS17): development and initial validation.计算机视觉症状量表(CVSS17):编制与初步验证。
Invest Ophthalmol Vis Sci. 2014 Jun 17;55(7):4504-11. doi: 10.1167/iovs.13-13818.
9
Comparison on the vision-related quality of life between outpatients and general population with dry eye syndrome.比较干眼症门诊患者和一般人群的视觉相关生活质量。
Acta Ophthalmol. 2014 Mar;92(2):e124-32. doi: 10.1111/aos.12204. Epub 2013 Jul 31.
10
Psychometric properties and validation of the Standard Patient Evaluation of Eye Dryness questionnaire.《干眼临床诊断标准患者评估问卷》的心理测量学特性和验证。
Cornea. 2013 Sep;32(9):1204-10. doi: 10.1097/ICO.0b013e318294b0c0.

引用本文的文献

1
Dry eye-related tear biomarkers MMP-2, MMP-13, and IFN-γ: potential predictors of Type III acute acquired concomitant esotropia.与干眼相关的泪液生物标志物基质金属蛋白酶-2(MMP-2)、基质金属蛋白酶-13(MMP-13)和干扰素-γ(IFN-γ):Ⅲ型急性后天性共同性内斜视的潜在预测指标。
Eur J Med Res. 2025 Jul 24;30(1):663. doi: 10.1186/s40001-025-02941-5.
2
Evaluation of pharmacological activities of medicinal mushrooms in the context of dry eye disease.干眼症背景下药用蘑菇的药理活性评估
Front Pharmacol. 2025 Mar 5;16:1557359. doi: 10.3389/fphar.2025.1557359. eCollection 2025.
3
Psychometric validation of the Chronic Ocular Pain Questionnaire (COP-Q).
慢性眼痛问卷(COP-Q)的心理测量学验证
J Patient Rep Outcomes. 2025 Mar 12;9(1):32. doi: 10.1186/s41687-025-00862-9.
4
Performance and Safety of a Sodium Hyaluronate, Xanthan Gum, and Osmoprotectants Ophthalmic Solution in the Treatment of Dry Eye Disease: An Observational Clinical Investigation.透明质酸钠、黄原胶和渗透保护剂眼药水治疗干眼病的疗效与安全性:一项观察性临床研究。
Ophthalmol Ther. 2025 Apr;14(4):675-692. doi: 10.1007/s40123-025-01099-x. Epub 2025 Feb 21.
5
From Symptoms to Satisfaction: Optimizing Patient-Centered Care in Dry Eye Disease.从症状到满意度:优化干眼症的以患者为中心的护理
J Clin Med. 2025 Jan 1;14(1):196. doi: 10.3390/jcm14010196.
6
Near Add Power of Glaucoma Patients with Early Presbyopia.早期老花眼青光眼患者的近附加屈光度
J Clin Med. 2024 Sep 24;13(19):5675. doi: 10.3390/jcm13195675.
7
Prevalence of dry eye disease symptoms, associated factors and impact on quality of life among medical students during the pandemic.疫情期间医学生干眼症状的流行情况、相关因素及其对生活质量的影响。
Sci Rep. 2024 Oct 14;14(1):23986. doi: 10.1038/s41598-024-75345-w.
8
Psychometric validation of the Chinese version of the dry eye-related quality-of-life score questionnaire.干眼症相关生活质量评分问卷中文版的心理测量学验证
Int J Ophthalmol. 2024 Sep 18;17(9):1614-1620. doi: 10.18240/ijo.2024.09.06. eCollection 2024.
9
Effectiveness of cyclosporine nanoemulsion eye drops in patients with mild-to-moderate dry eyes: objective and subjective evaluation.环孢素纳米乳滴眼液治疗轻中度干眼的有效性:客观和主观评价。
BMC Ophthalmol. 2024 Sep 9;24(1):401. doi: 10.1186/s12886-024-03620-5.
10
Presbyopia, Dry Eye, and Retinal Thickness in the Middle-Aged Population: Focusing on Sex Differences.中年人群中的老花眼、干眼症与视网膜厚度:聚焦性别差异
Clin Optom (Auckl). 2024 Sep 2;16:223-231. doi: 10.2147/OPTO.S481279. eCollection 2024.